Stock

What the S&P 500, VIX, and ARKK are Telling Us Now

Read more
Stock

Three Sectors Stand Out and One Sports a Bullish Breakout

Read more
Stock

Is a Bold Rotation Brewing in Healthcare and Biotech? Here’s What to Watch Now

Read more
Stock

Bearish Divergence Suggests Caution For S&P 500

Read more
Investing

Harvest Gold Announces Annual General Meeting Results

Read more
Investing

Editor’s Picks: Trump to Lift Minnesota Mining Ban, Dundee Buys Adriatic, China Tightens Rare Earth Grip

Read more
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Q1 2025 Management’s Discussion and Analysis

May 14, 2025

Allied Critical Metals Announces Corporate Update

May 17, 2025

Should You Invest in Silver Bullion?

June 6, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025

ARR advances permitting at Cowboy State Mine

May 28, 2025

FireFly Metals to Add AU$95 Million to Coffers...

June 12, 2025

Crypto Market Recap: Strategy Eyes US$1 Billion Capital...

June 7, 2025

High-Grade Gold Samples extend Clifton East Strike to...

May 22, 2025

Uranium Stocks: 5 Biggest Companies in 2025

May 20, 2025

Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts...

May 24, 2025